# Nasonex® Nasal Suspension 50 μg Long-term Designated Drug Use Investigation (Study P05876)

> **NCT00903721** · — · COMPLETED · sponsor: **Organon and Co** · enrollment: 3806 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** mometasone furoate

## Key facts

- **NCT ID:** NCT00903721
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 3806 (ACTUAL)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00903721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00903721, "Nasonex® Nasal Suspension 50 μg Long-term Designated Drug Use Investigation (Study P05876)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00903721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*